Article citationsMore>>

Grubber, J.M., Saunders, A.M., Crane-Gatherum, A.R., Scott, W.K., Martin, E.R., Haynes, C.S., Conneally, P.M., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A. (1999) Analysis of Association between Alzheimer’s Disease and the K Variant of Butyrylcholinesterase (BCHE-K). Neuroscience Letters, 269, 115-119. http://dx.doi.org/10.1016/S0304-3940(99)00426-7

has been cited by the following article:

• TITLE: Prevalence of Wild-Type Butyrylcholinesterase Genotype in Patients with Alzheimer’s Dementia

  AUTHORS: Beate Mueller, Georg Adler

  KEYWORDS: Butyrylcholinesterase, Alzheimer’s Disease, Genotype

  JOURNAL NAME: World Journal of Neuroscience, Vol.5 No.3, June 2, 2015

  ABSTRACT: Approximately, two-thirds patients with Alzheimer’s disease (AD) are reported to have homozygous wild-type butyrylcholinesterase (BuChE) gene expression. It is associated with a higher rate of hydrolysis of acetylcholine, which ultimately leads to increase in the levels of BuChE in advanced stages of the disease. Rivastigmine, a dual inhibitor of acetylcholinesterase (AChE) and BuChE, might be of additional benefit in patients with AD with wild-type BuChE allele.